Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced <scp>NSCLC</scp> Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single‐Arm Study
Radiotherapy combined with sintilimab for NSCLC patients who progressed after first-or second-line therapy showed promising efficacy outcomes.
Authors
- Xiaoyi Feng (ORCID: https://orcid.org/0000-0003-2891-8991)
- Yan Xu (ORCID: https://orcid.org/0009-0001-4936-7132)
- Mengzhao Wang
- Minjiang Chen (ORCID: https://orcid.org/0000-0002-4040-6115)
- Feng Gao (ORCID: https://orcid.org/0000-0001-7490-4887)
- Xiaoxing Gao
- Jing Zhao (ORCID: https://orcid.org/0009-0009-5127-1568)
- Hui Guan (ORCID: https://orcid.org/0000-0003-4377-2644)
- Chun‐Hong Chen (ORCID: https://orcid.org/0000-0002-5166-9017)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/1759-7714.70043
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Innovent Biologics
- Peking Union Medical College Hospital